Friday, July 10, 2026

Drug profile · INN

iopromide

iopromide (ULTRAVIST (PHARMACY BULK)) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — iopromide
US status
approved
Class
Route
INJECTION
Patents
0
Programs
2
Data quality
0.84

Quick answer

iopromide (ULTRAVIST (PHARMACY BULK)) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN iopromide
Brand ULTRAVIST (PHARMACY BULK)
Mechanism Diagnostic agent
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Ultravist /ml soluzione iniettabile for breast pathology Phase 2 · Telethon Foundation · breast pathology
  2. Ultravist 370 mg/ml soluzione iniettabile Phase 2 · Istituto Gentili Italia · Patients with breast lesions undergoing further examination

Frequently asked questions

What is iopromide?

iopromide (ULTRAVIST (PHARMACY BULK)) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for iopromide?

ULTRAVIST (PHARMACY BULK) is a marketed brand name for iopromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of iopromide?

iopromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.